AI-enhanced polynucleotide engineering to create highly stable, specific, and programmable RNA therapeutics that combine gene‑editing durability with safe, reversible modulation of disease mechanisms. Scalable, modular medicines designed to address unmet therapeutic needs across a wide range of diseases.